VA
GOSS icon

VestGen Advisors’s Gossamer Bio GOSS Stock Holding History

VestGen Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66K Sell
16,177
-1,260
-7% -$352 ﹤0.01% 1090
2026
Q1 		$5.94K Buy
+17,437
New +$27.4K ﹤0.01% 1047

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

VestGen Advisors's GOSS Position: Q2 2026 in Review

VestGen Advisors reduced its Gossamer Bio (GOSS) stake by 7.2% in Q2 2026, selling an estimated $352 and leaving 16,177 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

VestGen Advisors first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.94K in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • VestGen Advisors held 16,177 shares of Gossamer Bio worth $2.66K as of Q2 2026.
  • VestGen Advisors sold 1,260 Gossamer Bio shares in Q2 2026, an estimated $352.
  • Gossamer Bio made up ﹤0.01% of VestGen Advisors's portfolio in Q2 2026, its #1090 holding.
  • VestGen Advisors first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • VestGen Advisors's Gossamer Bio position peaked at $5.94K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.